); CDC alternative definition: Resistance to isoniazid, rifampin, any fluoroquinolone, and either bedaquiline or linezolid (or both) The diagnosis of MDR-TB and consequent need to use second-line drugs has great significance in terms of length, cost, and success of treatment.